Companies: 10,795·Total market cap: $144.5T
Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTANASDAQHealthcare● Active
$3.44
$-0.04(-1.15%)
Market Cap$31325071
P/E Ratio
52W High$5.07
52W Low$1.81
Overview

Lisata Therapeutics, Inc. (LSTA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LSTA · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Lisata Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

LSTA insider buying and selling by quarter

LSTA insider selling · LSTA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
279K140K0
2024 Q1
2024 Q2
2024 Q4
2025 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · LSTA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LSTA executive sell shares · LSTA board member insider trading · LSTA insider trading SEC filing

Showing 68 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Mazzo David J

President & CEO · Director

Award

Date

Jan 9

Shares

81,000

Price

Value

View Form 4 on SEC.gov

Mazzo David J

President & CEO · Director

Other

Date

Jan 9

Shares

10,503

Price

$1.97

Value

$21K

View Form 4 on SEC.gov

Mazzo David J

President & CEO · Director

Other

Date

Jan 9

Shares

10,515

Price

$1.97

Value

$21K

View Form 4 on SEC.gov

Mazzo David J

President & CEO · Director

Other

Date

Jan 9

Shares

12,224

Price

$1.97

Value

$24K

View Form 4 on SEC.gov

Mazzo David J

President & CEO · Director

Other

Date

Jan 9

Shares

7,854

Price

$1.97

Value

$15K

View Form 4 on SEC.gov

Nisco James

SVP, Fin/Treas, Chief Actg Off

Award

Date

Jan 9

Shares

15,000

Price

Value

View Form 4 on SEC.gov

Nisco James

SVP, Fin/Treas, Chief Actg Off

Other

Date

Jan 9

Shares

2,131

Price

$1.97

Value

$4K

View Form 4 on SEC.gov

Nisco James

SVP, Fin/Treas, Chief Actg Off

Other

Date

Jan 9

Shares

2,131

Price

$1.97

Value

$4K

View Form 4 on SEC.gov

Nisco James

SVP, Fin/Treas, Chief Actg Off

Other

Date

Jan 9

Shares

1,137

Price

$1.97

Value

$2K

View Form 4 on SEC.gov

Nisco James

SVP, Fin/Treas, Chief Actg Off

Other

Date

Jan 9

Shares

781

Price

$1.97

Value

$2K

View Form 4 on SEC.gov

Imam Tariq

SVP, Bus Dev, General Counsel

Award

Date

Jan 9

Shares

15,000

Price

Value

View Form 4 on SEC.gov

Imam Tariq

SVP, Bus Dev, General Counsel

Other

Date

Jan 9

Shares

1,401

Price

$1.97

Value

$3K

View Form 4 on SEC.gov

Imam Tariq

SVP, Bus Dev, General Counsel

Other

Date

Jan 9

Shares

840

Price

$1.97

Value

$2K

View Form 4 on SEC.gov

Imam Tariq

SVP, Bus Dev, General Counsel

Other

Date

Jan 9

Shares

747

Price

$1.97

Value

$1K

View Form 4 on SEC.gov

Imam Tariq

SVP, Bus Dev, General Counsel

Other

Date

Jan 9

Shares

513

Price

$1.97

Value

$1K

View Form 4 on SEC.gov

Buck Kristen K

EVP, R&D and CMO

Award

Date

Jan 9

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Buck Kristen K

EVP, R&D and CMO

Other

Date

Jan 9

Shares

2,982

Price

$1.97

Value

$6K

View Form 4 on SEC.gov

Buck Kristen K

EVP, R&D and CMO

Other

Date

Jan 9

Shares

2,982

Price

$1.97

Value

$6K

View Form 4 on SEC.gov

Buck Kristen K

EVP, R&D and CMO

Other

Date

Jan 9

Shares

3,221

Price

$1.97

Value

$6K

View Form 4 on SEC.gov

Buck Kristen K

EVP, R&D and CMO

Other

Date

Jan 9

Shares

2,147

Price

$1.97

Value

$4K

View Form 4 on SEC.gov

KLOSK STEVEN M

Director

Award

Date

Jan 9

Shares

30,456

Price

Value

View Form 4 on SEC.gov

HENSON HEIDI

Director

Award

Date

Jan 9

Shares

30,456

Price

Value

View Form 4 on SEC.gov

Flowers Cynthia Louise

Director

Award

Date

Jan 9

Shares

30,456

Price

Value

View Form 4 on SEC.gov

BROWN GREGORY B

Director

Award

Date

Jan 9

Shares

30,456

Price

Value

View Form 4 on SEC.gov

AZAB MOHAMMAD

Director

Award

Date

Jan 9

Shares

30,456

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LSTA insider trading

LSTA insider trades

Lisata Therapeutics, Inc. (LSTA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Mazzo David J (President & CEO · Director), Nisco James (SVP, Fin/Treas, Chief Actg Off), Imam Tariq (SVP, Bus Dev, General Counsel). Over the past 12 months, 5 insiders have filed transactions with the SEC. LSTA insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Lisata Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

LSTA insider trading · 5 questions

The insiders of Lisata Therapeutics, Inc. (LSTA) include executives and directors such as Mazzo David J (President & CEO · Director), Nisco James (SVP, Fin/Treas, Chief Actg Off), Imam Tariq (SVP, Bus Dev, General Counsel), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LSTA board member insider tradingwho are LSTA insidersLSTA insider rosterLisata Therapeutics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026